Comments
Loading...

Agilon Health Inc Analyst Ratings

AGLNYSE
$0.3610
-0.0024-0.66%
At close: Feb 13, 4:00 PM EST
$0.3667
0.00571.58%
After Hours: 4:51 PM EST
Earnings: Q4 2025 Earnings in 12 days from now on Wed Feb 25th, after the market close
Consensus Rating1
Hold
Highest Price Target1
$30.00
Lowest Price Target1
$1.00
Consensus Price Target1
$4.58

Agilon Health Analyst Ratings and Price Targets | NYSE:AGL | Benzinga

Agilon Health Inc has a consensus price target of $4.58 based on the ratings of 27 analysts. The high is $30 issued by Guggenheim on March 6, 2023. The low is $1 issued by Barclays on November 6, 2025. The 3 most-recent analyst ratings were released by Barclays, Wells Fargo, and Wells Fargo on November 6, 2025, November 5, 2025, and October 7, 2025, respectively. With an average price target of $1.17 between Barclays, Wells Fargo, and Wells Fargo, there's an implied 218.15% upside for Agilon Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

2
Aug 25
1
Oct 25
1
1
Nov 25
1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
Wells Fargo
Bernstein
Jefferies
Baird

1calculated from analyst ratings

Analyst Ratings for Agilon Health

Buy NowGet Alert
12/12/2025Buy Now—BTIG—SuspendsNeutral → NeutralGet Alert
11/06/2025Buy Now172.7%Barclays$1.5 → $1MaintainsUnderweightGet Alert
11/05/2025Buy Now172.7%Wells Fargo$1.5 → $1MaintainsOverweightGet Alert
10/07/2025Buy Now309.05%Wells Fargo$5 → $1.5MaintainsOverweightGet Alert
08/20/2025Buy Now281.78%Bernstein$4 → $1.4DowngradeOutperform → Market PerformGet Alert
08/15/2025Buy Now199.97%Jefferies$2.4 → $1.1MaintainsHoldGet Alert
08/14/2025Buy Now172.7%Baird$5 → $1MaintainsNeutralGet Alert
08/06/2025Buy Now309.05%Benchmark$4 → $1.5MaintainsBuyGet Alert
08/06/2025Buy Now309.05%Barclays$3 → $1.5MaintainsUnderweightGet Alert
08/06/2025Buy Now172.7%Citigroup$3 → $1DowngradeBuy → NeutralGet Alert
07/09/2025Buy Now718.11%Evercore ISI Group$5 → $3MaintainsIn-LineGet Alert
05/29/2025Buy Now1945.27%Bernstein$7.5 → $7.5MaintainsOutperformGet Alert
05/13/2025Buy Now1263.51%Wells Fargo$6 → $5MaintainsOverweightGet Alert
05/08/2025Buy Now718.11%Barclays$2 → $3MaintainsUnderweightGet Alert
05/08/2025Buy Now1263.51%Goldman Sachs$2.5 → $5MaintainsNeutralGet Alert
04/28/2025Buy Now—JMP Securities—ReiteratesMarket Perform → Market PerformGet Alert
04/25/2025Buy Now1263.51%Citigroup$3.25 → $5UpgradeNeutral → BuyGet Alert
04/15/2025Buy Now1536.21%TD Cowen$3.5 → $6MaintainsHoldGet Alert
04/15/2025Buy Now1263.51%Baird$6 → $5MaintainsNeutralGet Alert
04/08/2025Buy Now1536.21%Wells Fargo$5 → $6MaintainsOverweightGet Alert
04/08/2025Buy Now2217.97%Bernstein$3.3 → $8.5UpgradeMarket Perform → OutperformGet Alert
03/21/2025Buy Now—Needham—ReiteratesHold → HoldGet Alert
02/26/2025Buy Now854.46%RBC Capital$3 → $3.5MaintainsOutperformGet Alert
02/26/2025Buy Now—Citizens Capital Markets—ReiteratesMarket Perform → Market PerformGet Alert
02/26/2025Buy Now718.11%Stifel$2 → $3MaintainsHoldGet Alert
02/26/2025Buy Now—Needham—ReiteratesHold → HoldGet Alert
01/15/2025Buy Now759.01%Bernstein$2.5 → $3.15MaintainsMarket PerformGet Alert
01/10/2025Buy Now513.58%Citigroup$1.75 → $2.25UpgradeSell → NeutralGet Alert
01/10/2025Buy Now—Needham—ReiteratesHold → HoldGet Alert
12/16/2024Buy Now718.11%Macquarie → $3Initiates → NeutralGet Alert
12/11/2024Buy Now581.76%Bernstein → $2.5Initiates → Market PerformGet Alert
11/19/2024Buy Now718.11%RBC Capital$3 → $3ReiteratesOutperform → OutperformGet Alert
11/13/2024Buy Now377.23%Citigroup$2.5 → $1.75MaintainsSellGet Alert
11/12/2024Buy Now445.4%Stifel$7 → $2MaintainsHoldGet Alert
11/11/2024Buy Now445.4%TD Cowen$6 → $2MaintainsHoldGet Alert
11/11/2024Buy Now445.4%Barclays$5 → $2MaintainsUnderweightGet Alert
11/11/2024Buy Now—JMP Securities—DowngradeMarket Outperform → Market PerformGet Alert
11/08/2024Buy Now445.4%Deutsche Bank$4 → $2MaintainsHoldGet Alert
11/08/2024Buy Now—William Blair—DowngradeOutperform → Market PerformGet Alert
10/29/2024Buy Now581.76%Citigroup$7 → $2.5DowngradeNeutral → SellGet Alert
10/08/2024Buy Now990.81%Evercore ISI Group$7 → $4MaintainsIn-LineGet Alert
10/02/2024Buy Now718.11%B of A Securities → $3DowngradeBuy → UnderperformGet Alert
08/09/2024Buy Now990.81%Deutsche Bank$5 → $4MaintainsHoldGet Alert
08/08/2024Buy Now2354.32%Benchmark$9 → $9ReiteratesBuy → BuyGet Alert
08/07/2024Buy Now2081.62%RBC Capital$8 → $8ReiteratesOutperform → OutperformGet Alert
07/09/2024Buy Now1808.92%Evercore ISI Group$5.5 → $7MaintainsIn-LineGet Alert
05/30/2024Buy Now1536.21%Baird → $6Initiates → NeutralGet Alert
05/24/2024Buy Now1672.57%Truist Securities$6.4 → $6.5MaintainsHoldGet Alert
05/09/2024Buy Now1263.51%Deutsche Bank$8 → $5MaintainsHoldGet Alert
05/01/2024Buy Now1808.92%Stifel$8 → $7MaintainsHoldGet Alert
04/22/2024Buy Now1536.21%Citigroup → $6Initiates → NeutralGet Alert
04/15/2024Buy Now1645.3%Truist Securities$7.5 → $6.4MaintainsHoldGet Alert
03/06/2024Buy Now1263.51%Barclays → $5Initiates → UnderweightGet Alert
02/29/2024Buy Now1945.27%Truist Securities$10 → $7.5MaintainsHoldGet Alert
02/29/2024Buy Now2354.32%Benchmark$13 → $9MaintainsBuyGet Alert
02/28/2024Buy Now1536.21%Evercore ISI Group$7 → $6MaintainsIn-LineGet Alert
02/28/2024Buy Now2081.62%RBC Capital$11 → $8MaintainsOutperformGet Alert
02/26/2024Buy Now2081.62%Wells Fargo$16 → $8MaintainsOverweightGet Alert
02/26/2024Buy Now1672.57%TD Cowen$12 → $6.5DowngradeOutperform → Market PerformGet Alert
02/22/2024Buy Now2354.32%Stifel$10 → $9MaintainsHoldGet Alert
01/08/2024Buy Now—Wolfe Research—DowngradeOutperform → Peer PerformGet Alert
01/05/2024Buy Now2627.02%Truist Securities$23 → $10DowngradeBuy → HoldGet Alert
01/05/2024Buy Now2354.32%JP Morgan$17 → $9DowngradeOverweight → NeutralGet Alert
12/13/2023Buy Now4535.94%JP Morgan$36 → $17MaintainsOverweightGet Alert
12/11/2023Buy Now—Goldman Sachs—DowngradeBuy → NeutralGet Alert
12/06/2023Buy Now4808.64%JMP Securities → $18Initiates → Market OutperformGet Alert
11/21/2023Buy Now3172.43%Deutsche Bank$27 → $12DowngradeBuy → HoldGet Alert
11/15/2023Buy Now5899.45%Benchmark$28 → $22MaintainsBuyGet Alert
11/13/2023Buy Now4263.24%Wells Fargo$23 → $16MaintainsOverweightGet Alert
11/09/2023Buy Now6172.16%Truist Securities$27 → $23MaintainsBuyGet Alert
11/09/2023Buy Now5899.45%Goldman Sachs$25 → $22MaintainsBuyGet Alert
11/03/2023Buy Now6172.16%RBC Capital$28 → $23MaintainsOutperformGet Alert
10/20/2023Buy Now7535.67%Benchmark → $28Initiates → BuyGet Alert
08/15/2023Buy Now6717.56%Goldman Sachs$29 → $25MaintainsBuyGet Alert
08/15/2023Buy Now6717.56%TD Cowen$29 → $25MaintainsOutperformGet Alert
06/20/2023Buy Now7262.97%Truist Securities$35 → $27MaintainsBuyGet Alert
06/13/2023Buy Now6035.81%Evercore ISI Group → $22.5Initiates → In-LineGet Alert
05/31/2023Buy Now7808.37%Goldman Sachs$32 → $29MaintainsBuyGet Alert
05/15/2023Buy Now7262.97%Deutsche Bank$28 → $27MaintainsBuyGet Alert
05/10/2023Buy Now8899.18%RBC Capital → $33Reiterates → OutperformGet Alert
05/10/2023Buy Now8626.48%Stifel$29 → $32MaintainsBuyGet Alert
04/17/2023Buy Now9444.59%Truist Securities$29 → $35MaintainsBuyGet Alert
03/06/2023Buy Now8081.07%Guggenheim$21 → $30MaintainsBuyGet Alert
03/03/2023Buy Now7535.67%Deutsche Bank$26 → $28MaintainsBuyGet Alert

FAQ

Q

What is the target price for Agilon Health (AGL) stock?

A

The latest price target for Agilon Health (NYSE:AGL) was reported by BTIG on December 12, 2025. The analyst firm set a price target for $0.00 expecting AGL to fall to within 12 months (a possible -100.00% downside). 26 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE:AGL) was provided by BTIG, and Agilon Health their neutral rating.

Q

When was the last upgrade for Agilon Health (AGL)?

A

The last upgrade for Agilon Health Inc happened on April 25, 2025 when Citigroup raised their price target to $5. Citigroup previously had a neutral for Agilon Health Inc.

Q

When was the last downgrade for Agilon Health (AGL)?

A

The last downgrade for Agilon Health Inc happened on August 20, 2025 when Bernstein changed their price target from $4 to $1.4 for Agilon Health Inc.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on December 12, 2025 so you should expect the next rating to be made available sometime around December 12, 2026.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a with a price target of $0.00 to $0.00. The current price Agilon Health (AGL) is trading at is $0.37, which is out of the analyst’s predicted range.